Intravacc and Primrose Bio have announced a strategic collaboration aimed at bolstering the conjugate vaccine development and ...
Moderna announced a significant boost to its vaccine development efforts with a substantial injection of funds from ...
A $70 million pilot program to deliver malaria vaccines was rolled out in Africa in 2019, and analysis of the initiative has ...
Moderna continues on the competitive path with Pfizer as they hope to diversify revenue streams after the demand for Covid ...
Moderna is focusing on advancing its mRNA vaccine pipeline for other viruses following a decline in COVID-19 product sales.
Moderna’s ambitious plan to become the leader in vaccine development, with 28 vaccine programs in the pipeline and an estimated total addressable market of over $52 billion, speaks to its potential ...
Moderna’s COVID-19 vaccine was a blockbuster. Highly anticipated shots protecting against respiratory syncytial virus and ...
Dengue fever, a mosquito-borne viral infection, poses a significant public health challenge in India. With nearly a third of ...
Blackstone (NYSE:BX) announced on Wednesday that funds managed by Blackstone Life Sciences would provide up to $750 million ...
The companies will leverage their combined experience in the development of conjugate vaccines for their clientsPrimrose Bio will supply its industry-leading carrier protein, PeliCRM197®, for vaccine ...
As measles cases pop up in California and elsewhere, pediatricians are becoming more concerned with one group of children – ...
“This technology opens an entirely new path for development of designer vaccines with properties tailored to meet specific ...